ACTH-independent macronodular adrenal hyperplasia

Area of Science:

• Endocrinology
• Genetics
• Pathophysiology

Background:

• Adrenocorticotropic hormone-independent macronodular adrenal hyperplasia (AIMAH) is an uncommon cause of Cushing's syndrome (CS).
• AIMAH can manifest as an incidental finding or present with subclinical or overt CS, sometimes involving mineralocorticoid or sex steroid secretion.
• Its pathophysiology is complex and heterogeneous.

Purpose of the Study:

• To elucidate the diverse pathophysiological mechanisms underlying AIMAH.
• To highlight the role of aberrant G-protein-coupled receptors and genetic events in AIMAH development.
• To discuss the implications for pharmacological and surgical treatment strategies.

Main Methods:

• Review of existing literature on AIMAH pathophysiology.
• Analysis of genetic factors, including aberrant receptor expression and somatic mutations.
• Examination of clinical presentations and treatment outcomes.

Main Results:

• Aberrant adrenal expression and function of G-protein-coupled receptors contribute to cell proliferation and dysregulated steroidogenesis in AIMAH.
• Familial cases often involve functional, specific aberrant hormone receptors.
• Somatic genetic events affecting cell cycle, adhesion, and transcription factors are observed within nodules.
• Rarely, Gsp or ACTH receptor mutations and paracrine secretion are implicated.

Conclusions:

• Identifying aberrant receptors in AIMAH offers potential for targeted pharmacological interventions.
• Treatment options include specific medications or adrenalectomy (unilateral or bilateral).
• Further research into AIMAH's genetic underpinnings is crucial for advancing patient care.